US$ 28.96
glp-1 ulcerative colitis Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review Relevance of Glucagon-Like Peptide 1
Description
This review underscores the necessity of early recognition, accurate diagnosis, and tailored interventions to mitigate complications and enhance patient outcomes

Anodyne Nanotech announced today that it closed a $12.6 million Series A financing to support its transdermal drug delivery technology.

Source: Indian Journal of Gastroenterology

The use of GLP-1 analogs is growing rapidly in obese and overweight patients who need to control body weight.

The consistent, substantial kidney and cardiovascular benefits of these agents has led to their incorporation into professional guidelines as foundational care for type 2 diabetes

If you are taking medications or have a medical condition, speak with your provider before use
